A Study to Evaluate the Effect of Spinal Cord Stimulation (SCS) on Painful Diabetic Peripheral Neuropathy (pDPN)
CompletedNot applicableNCT05302063
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of the study is to evaluate the effects of stimulation parameters on clinical outcomes of Spinal Cord Stimulation (SCS) in the treatment of chronic, intractable limb pain resulting from painful Diabetic Peripheral Neuropathy (pDPN).
Study details
- Official title
- A Study to Evaluate the Effect of Spinal Cord Stimulation (SCS) on Clinical Outcomes and Pathology of Painful Diabetic Peripheral Neuropathy (pDPN)
- Conditions
- Interventions
- Device: Spinal Cord Stimulation (SCS)
- Sponsor
- Boston Scientific Corporation
- Start date
- 2022-09-22
- Primary completion
- 2026-05-22
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Key Inclusion Criteria: * Clinical diagnosis of diabetes mellitus, according to International Diabetes guidelines. * Willing and able to comply with all protocol-required procedures and assessments/evaluations. * Eligible candidate for SCS from a surgical, cognitive, psychological and psychiatric standpoint per site's routine screening process and based on investigator judgement. * Subject signed a valid, EC-approved informed consent form (ICF) provided in local language. Key Exclusion Criteria: * Primary etiology for lower limb neuropathic pain not due to Diabetic Peripheral Neuropathy (DPN). * Participating (or intends to participate) in another drug or device clinical trial that may influence the data that will be collected for this study. * Currently implanted with an active implantable device(s) (e.g., pacemaker, drug pump). * A female who is pregnant, lactating, or is of childbearing potential and planning to get pregnant during the study or not using adequate contraception.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05302063